SV2A and Parkinson disease: These findings are in line with previous conclusions drawn using the [11C]UCB-J radiotracer and shows comparability between both radiotracers.15-18 Building on previous research that supports the use of SV2A as a proxy of synaptic density,11,27 we provide further evidence that synaptic dysfunction is a feature of PD pathology.